Innokaiz India IPO vs Remus Pharmaceuticals IPO

Comparision between Innokaiz India IPO and Remus Pharmaceuticals IPO.

IPO Details

Innokaiz India IPO is a SME Book Built Issue IPO proposed to list at BSE SME while Remus Pharmaceuticals IPO is a SME Book Built Issue proposed to list at NSE SME.

	Innokaiz India IPO	Remus Pharmaceuticals IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE SME	NSE SME
Lead Managers	Gretex Corporate Services Limited	Beeline Capital Advisors Pvt Ltd
Registrar	Bigshare Services Pvt Ltd	Link Intime India Private Ltd
Market Maker	Gretex Share Broking Private Limited	Sunflower Broking Private Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Innokaiz India IPO is up to ₹21.17 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹47.69 Cr. The final issue price of Innokaiz India IPO is ₹78.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.

	Innokaiz India IPO	Remus Pharmaceuticals IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹76.00 per share	₹1,150.00 per share
Issue Price (Upper)	₹78.00 per share	₹1,229.00 per share
Issue Price (Final)	₹78.00 per share	₹1,229.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	1600 shares	100 shares
Fresh Issue Size	27,13,600 shares	3,88,000 shares
Fresh Issue Size (Amount)	up to ₹21.17 Cr	up to ₹47.69 Cr
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	27,13,600 shares	3,88,000 shares
Issue Size Total (Amount)	up to ₹21.17 Cr	up to ₹47.69 Cr

IPO Timetable

Innokaiz India IPO opens on Apr 28, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Innokaiz India IPO and Remus Pharmaceuticals IPO is May 03, 2023, and May 19, 2023, respectively.

	Innokaiz India IPO	Remus Pharmaceuticals IPO
Anchor Bid Date	Apr 27, 2023	May 16, 2023
Issue Open	Apr 28, 2023	May 17, 2023
Issue Close	May 03, 2023	May 19, 2023
Basis Of Allotment (Tentative)	May 08, 2023	May 24, 2023
Initiation of Refunds (Tentative)	May 09, 2023	May 25, 2023
Credit of Share (Tentative)	May 10, 2023	May 26, 2023
Listing date (Tentative)	May 11, 2023	May 29, 2023
Anchor Lockin End date 1	Jun 07, 2023	Jun 23, 2023
Anchor Lockin End date 2	Aug 06, 2023	Aug 22, 2023

Financials

Innokaiz India IPO P/E ratio is , as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.

Innokaiz India IPO

Remus Pharmaceuticals IPO

Financial

Innokaiz India Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	2,568.38	13,872.44	361.55	541.93	540.93	110.60
31-Mar-21	3,871.07	18,506.21	509.15	1,051.09	1,050.09	103.52
31-Mar-22	4,972.47	28,609.09	791.63	1,842.72	1,841.72	132.17
31-Oct-22	4,763.15	14,883.52	610.28	2,453.00	1,702.00	93.62
Amount in ₹ Lakhs

Remus Pharmaceuticals Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	530.36	1,276.89	81.16	202.03	201.03	35.93
31-Mar-21	1,104.96	1,922.45	102.58	304.61	303.61	27.89
31-Mar-22	1,590.93	2,543.71	338.57	643.17	543.17	19.17
31-Dec-22	3,352.96	3,361.20	643.90	1,712.07	1,603.57	947.45
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

98.00

92.82%

Promoter Shareholding (Post-Issue)

71.99

68.37%

P/E Ratio

21.09

Market Cap

₹181.03 Cr.

ROE

71.44%%

ROCE

69.99%%

Debt/Equity

0.03

EPS

₹33.86

RoNW

52.64%%

Shares Offered

In the Innokaiz India IPO retail investors (RII) are offered 9,02,400 shares while in Remus Pharmaceuticals IPO retail investors are offered 9,02,400 shares. Qualified institutional buyers (QIB) are offered 5,15,200 shares in Innokaiz India IPO and 1,38,750 shares in Remus Pharmaceuticals IPO.

	Innokaiz India IPO	Remus Pharmaceuticals IPO
Anchor Investor Reserveration	7,72,800 shares	1,10,500 shares
Market Maker Reserveration	1,36,000 shares	19,500 shares
QIB	5,15,200 shares	1,38,750 shares
NII	3,87,200 shares	41,625 shares
RII	9,02,400 shares	97,125 shares
Employee	0 shares	0 shares
Others
Total	18,04,800 shares	2,77,500 shares

Bids Received (Subscription)

Innokaiz India IPO subscribed 95.08x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.

	Innokaiz India IPO	Remus Pharmaceuticals IPO
QIB (times)	23.93x	10.75x
NII (times)	303.92x	229.31x
Big NII (times)
Small NII (times)
RII (times)	46.10x	49.81x
Employee (times)
Other (times)
Total (times)	95.08x	57.21x

Compare with others

Innokaiz India IPO	Remus Pharmaceuticals IPO
Vasa Denticity IPO	Proventus Agrocom IPO
Spectrum Talent Management IPO	Hemant Surgical Industries IPO
Crayons Advertising IPO	Vasa Denticity IPO
Remus Pharmaceuticals IPO	Spectrum Talent Management IPO
Auro Impex & Chemicals IPO	Crayons Advertising IPO
Krishca Strapping Solutions IPO	Auro Impex & Chemicals IPO
De Neers Tools IPO	Innokaiz India IPO
Quicktouch Technologies IPO	Krishca Strapping Solutions IPO
Retina Paints IPO	De Neers Tools IPO
A G Universal IPO	Quicktouch Technologies IPO

Comments

Add a public comment...